Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Broken down stinky pinks? lol yea stick with mstx then. This is the best turn around company you will find with actual big pharma management and real revenues from their generic business. Wait until they tap into the abuse deterrent market that is over 10 billion alone.. They just reported top line data as well in their phase III trial.
Good luck
Let me know what happens when their oxy drug gets approved within 6-8 months
20M in debt? Do some dd please
Maybe you should check out ELTP. Most undervalued stock on the OTC and soon to be NASDAQ
NY only problem with this company is if their product was so good why would the company who sold them vepoloxamer only sell it for 5 million? Can't get my head around that. Sure it wasn't performing well in trials and still a question mark, but surely the scientists behind it should've saw the potential in it to not sell it for a puny 5 million?
DD, all this revenue won't ever matter if it never reflects the share price, if this is simply a byproduct of being off the radar, what will it take to get on the radar,doesn't seem like the company cares to market their business
60M in revcenue and sitting at below a penny? The over inflated outstanding share count doesnt help/ There seems to be a disconnect here, the market doesnt appreciate what PXYN is doing or maybe it's just flat out under the radar. The debt seems to be very low as well, so I have no idea why the share price is not moving. Will keep an eye on this, but there seems to be something wrong here, going to read the 10Q later.
Small-cap cancer-focused stocks have a notoriously bad history of meeting their primary endpoint in phase 3 studies or having their drug approved by the FDA. That's why im pretty skeptical. I love the potential here, but small caps and cancer as history shows us do not go well together. We need top notch management to ride this through and im not sure Peregrine has it. Going to be a tough hurdle to get this through the FDA.
If only PPHM has experienced management, this could be labeled a gem in the making. But looking over each of the executives on this team, they seem to have no experience at all from any major companies or even in this sector
The only thing that worries me is the corrupt FDA. Just look at what they have been doing to slow down IPCI. The tech that IPCI has can literally 'cure' the epidemic of opioid abuse and we all know there will never be a 'cure' for anything in pharma. This is what worries me about this company. Big pharma and FDA don't want a cure for anything hence the reason they keep making up excuses that slow IPCI down
Interesting thanks. I'll start doing some DD
Unless IPCIs tech prevents the body's ability to absorb multiple pills. Is that it? Because no pill can ever stop someone from ingesting multiple pills unless that pill ties their hands behind their backs LOL
Interesting perspective thanks
I agree. No drug can make someone stop taking extra pills. Even if it made them numb, those types of people that want to abuse it will do so anyway whether they feel anything or not. Were talking about addicts here
Potential revenue for bavi? Potential market cap for bavi after approval? I'm aware it can be used for many indications which is a big plus but trying to fudge in some numbers right now before I do some DD.
I like this company, but the market cap seems to be too inflated at over 220 million. Seems overpriced imo
Great potential company, but this company bought their sickle cell drug from someone else for only 5 million I believe? If this drug was so good why would the company only sell it for 5 million? Yes I know the company was having trouble with the data and ran out of money etc, but you would think they would ask for more than 5 million?
No smallcap has ever got a cancer drug approved. Should make everyone holding PPHM nervous.
Why the recent drop off? Seems like a nice undervalued long term play?
Winning IS my primary objective and let's just say i win more often than I lose. Call me the rainman
Is that what you do? Welcome aboard my friend lol
Long run you will not make money in blackjack unless you count cards my friend or do some other type of advanced technicwue to gain an advantage. Simply playing basic strategy in blackjack and playing the right way does not give you the edge over the house. You might be winning short term but your luck will eventually run out
Even better when you are a professional blackjack player. ;)
From the recent SaeC filing it says AEZS only has 180M shares outstanding and about 70M in warrants. Does that mean 70M will still need to be converted?
This company seems to be reaching severely undervalued territory, but one still needs to know what's going on with these warrants. Will continue to watch this closely.
How much are they making off Estrogel at the moment? And what is the market potential for Zop and Macrillen? Hundreds of millions for each?
What's the market potential for each of their Phase IIIs? I don't think there's that much market potential in their drugs. I could be wrong, but from a quick glance, doesn't seem like it.
The bigger the smile, the one someone should be more cautious.
We broke .24 not too long ago stopped at 25 and fell back to .20
More like traders are jumping aboard and if no news at rodman, back to .20 we go
I'm actually trying to buy in before the rodman but funds don't clear until tmrw. Looks like karma got me lol. I said i wouldnt be chasing and now I am. O well. Was tryna get some .20s, don't really feel like buying in the .22s or .23s
Once we break .35 I'll take the run serious. It always rushes up only to fall back down. Traders seem to control this stock.
Theres nothing wrong with lying, its not bad or illegal. What you don't understand is that Nasrat is protected by the forward looking statement disclosure. He can day whatever the hell he wants. Wake up
Well its not a guarantee. The two bead polymer could be causing efficacy issues.
Do you got a link that the fluid bed dryer is even there and that their is a new facility or a bigger facility? Got a link?
OK if it starts at a higher price I'll put in about .02 to .03 higher and it'll get filled
But yet no one can tell me why. Price goes up through demand. Without people buying it up it won't move
I meant after the PR
Then how does the price ever go up, if people can't buy? Hmm